Some of these were supported by evidence in the literature, including BRAF-DUSP4, BRAF-MAPK1, and BRAF-PEA15 in skin, GATA3-ESR1 in breast, and CDH1-CTNNB1 in stomach cancers (Supplementary Data 2). Here, BRAF is linked to gastric neoplasm.